Yüklüyor......
Afatinib treatment in advanced non-small cell lung cancer
Despite some recent advances in the management of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains poor. Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have however provided a new therapeutic option in this disease setting an...
Kaydedildi:
| Yayımlandı: | Lung Cancer (Auckl) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312479/ https://ncbi.nlm.nih.gov/pubmed/28210118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S16310 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|